PLYVE Kicks Off First World Tour at a Stadium… Setting a New Milestone for Virtual Idols
Concert at Incheon Munhak Stadium on the 12th and 13th
Performing at a Stadium for the First Time Since Their Debut
Global Expansion Beyond Japan and Asia to Los Angeles
[Edaily Starin YUN GI BACK Reporter] Virtual idol group PLAVE is kicking off its first world tour at a stadium. This is highly symbolic, as it marks the expansion of a virtual idol group—which grew through online platforms—into large-scale offline performance venues. PLAVE (Photo: Blast) PLAVE will hold the “2026 PLAVE WORLD TOUR KEEP IT MANIC” at the main stadium of Incheon Munhak Stadium on the 12th and 13th. This marks their first world tour and their first stadium concert since their debut. This concert clearly demonstrates PLAVE’s upward trajectory. Having already confirmed their international fanbase through their Asian tour, they are now scaling up to a stadium-sized venue, putting their ability to draw live audiences to the test. The individual member posters released ahead of the concert also revisited their early-debut imagery. By utilizing red tones and close-up compositions, the posters highlight the members’ visuals, and by recreating poses from their debut video, they connect the starting point of their first world tour with their current status. The Incheon concert is set to feature a performance that encapsulates all the music and stage presence FLIVE has built up to this point. Interest is also high because this event will demonstrate whether the group can fill a large stage with their music and performance alone, transcending the unique format of being virtual characters. Starting in Incheon, PLYVE plans to continue their tour to Kanagawa, Kaohsiung, Bangkok, Singapore, Taipei, Macau, and Los Angeles (LA).
Chinese multilayer ceramic capacitor (MLCC) manufacturers are accelerating their entry into the global PC supply chain. They appear to be capitalizing on the supply gap in general-purpose MLCCs create…
SamilPharmaceutical(000520)With “Lorecivivint,” a new drug for osteoarthritis for which BioSplice holds exclusive domestic distribution rights, entering the regulatory review process in the UK followi…
Artificial intelligence (AI) translation and interpretation technology, which was previously used mainly in tourism and international conferences, is now making inroads into manufacturing and safety s…